Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T13:35:46.541Z.
Calculation as of: 2026-10-06T13:35:46.541Z.
Quote observation: 2026-10-06T13:34:49.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d0d16669f7a2c0e1646e6313a61118319ccaec2b3022f40527d46d929c834448
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$240.76M
Free Cash Flow Yield
4.77%
TTM Avg
5.58%
3Y Avg
6.49%
5Y Avg
6.20%
Market Cap
$239.39M
Free Cash Flow Yield
16.78%
TTM Avg
15.02%
3Y Avg
15.02%
5Y Avg
15.02%
Market Cap
$244.19M
Free Cash Flow Yield
N/A
TTM Avg
1.67%
3Y Avg
1.64%
5Y Avg
2.28%
Market Cap
$246.96M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$249.82M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$232.03M
Free Cash Flow Yield
N/A
TTM Avg
41.32%
3Y Avg
41.21%
5Y Avg
35.11%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $241.18M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $240.76M | 4.77% | 5.58% | 6.49% | 6.20% |
| Biodesix, Inc. (BDSX)vs › | $240.55M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $239.39M | 16.78% | 15.02% | 15.02% | 15.02% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.19M | N/A | 1.67% | 1.64% | 2.28% |
| Galectin Therapeutics Inc. (GALT)vs › | $246.96M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $248.92M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $249.82M | N/A | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $232.03M | N/A | 41.32% | 41.21% | 35.11% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $251.01M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
